Peritoneal Mesothelial Neoplasm — Trials

Peritoneal Mesothelial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

27 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06057935	A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma	recruiting	Phase 2	64	Memorial Sloan Kettering Cancer CenterOTHER	1	Sep 24, 2026	clinicaltrials
NCT05001880	Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma	recruiting	Phase 2	66	National Cancer Institute (NCI)NIH	1	Sep 22, 2026	clinicaltrials
NCT03074513	Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors	active not recruiting	Phase 2	133	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials
NCT02535312	Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

Data updated 5 days agoSource updated Sep 24, 2026source: clinicaltrials